Suppressive effect of AMP-activated protein kinase on the epithelial-mesenchymal transition in retinal pigment epithelial cells
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Suppressive effect of AMP-activated protein kinase on the epithelial-mesenchymal transition in retinal pigment epithelial cells
Authors
Keywords
-
Journal
PLoS One
Volume 12, Issue 7, Pages e0181481
Publisher
Public Library of Science (PLoS)
Online
2017-07-19
DOI
10.1371/journal.pone.0181481
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- AMPKα2 reduces renal epithelial transdifferentiation and inflammation after injury through interaction with CK2β
- (2015) Shulan Qiu et al. JOURNAL OF PATHOLOGY
- Trichostatin A, a histone deacetylase inhibitor, suppresses proliferation and epithelial-mesenchymal transition in retinal pigment epithelium cells
- (2014) Wei Xiao et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Molecular mechanisms of epithelial–mesenchymal transition
- (2014) Samy Lamouille et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Metformin Inhibits the IL-6-Induced Epithelial-Mesenchymal Transition and Lung Adenocarcinoma Growth and Metastasis
- (2014) Zhongquan Zhao et al. PLoS One
- Ranibizumab Is a Potential Prophylaxis for Proliferative Vitreoretinopathy, a Nonangiogenic Blinding Disease
- (2013) Steven Pennock et al. AMERICAN JOURNAL OF PATHOLOGY
- Inhibition of the TNF-α^|^ndash;Induced Serine Phosphorylation of IRS-1 at 636/639 by AICAR
- (2013) Tomohito Shibata et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Metformin reverses multidrug resistance and epithelial–mesenchymal transition (EMT) via activating AMP-activated protein kinase (AMPK) in human breast cancer cells
- (2013) Chen Qu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Inhibitory Effects of Resveratrol on PDGF-BB-Induced Retinal Pigment Epithelial Cell Migration via PDGFRβ, PI3K/Akt and MAPK pathways
- (2013) Chi-Ming Chan et al. PLoS One
- Pathophysiology of Proliferative Vitreoretinopathy in Retinal Detachment
- (2013) Justus G. Garweg et al. SURVEY OF OPHTHALMOLOGY
- Mechanisms of Inflammation in Proliferative Vitreoretinopathy: From Bench to Bedside
- (2012) Stavros N. Moysidis et al. MEDIATORS OF INFLAMMATION
- Enhanced PKCδ and ERK Signaling Mediate Cell Migration of Retinal Pigment Epithelial Cells Synergistically Induced by HGF and EGF
- (2012) Yu Jung Chen et al. PLoS One
- Epithelial-Mesenchymal Transition: General Principles and Pathological Relevance with Special Emphasis on the Role of Matrix Metalloproteinases
- (2012) P. Nistico et al. Cold Spring Harbor Perspectives in Biology
- AMP-activated Protein Kinase Suppresses Matrix Metalloproteinase-9 Expression in Mouse Embryonic Fibroblasts
- (2011) Yuki Morizane et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Tumor Necrosis Factor-α Regulates Transforming Growth Factor-β-dependent Epithelial-Mesenchymal Transition by Promoting Hyaluronan-CD44-Moesin Interaction
- (2009) Eri Takahashi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- mTOR signaling at a glance
- (2009) M. Laplante et al. JOURNAL OF CELL SCIENCE
- Role of TGF- in proliferative vitreoretinal diseases and ROCK as a therapeutic target
- (2008) T. Kita et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Epithelial-Mesenchymal Transition as a Therapeutic Target for Prevention of Ocular Tissue Fibrosis
- (2008) Shizuya Saika et al. Endocrine Metabolic & Immune Disorders-Drug Targets
- Inhibition of lipopolysaccharide-induced inducible nitric oxide synthase and cyclooxygenase-2 gene expression by 5-aminoimidazole-4-carboxamide riboside is independent of AMP-activated protein kinase
- (2007) Chih-Lin Kuo et al. JOURNAL OF CELLULAR BIOCHEMISTRY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started